2013China Medicine and PharmacyRequires access

Clinical observation of pantoprazple-based triple therapy for peptic ulcer

Ming Liang

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy of triple therapy with pantoprazple,clarithromycin and amoxicillin. Methods 85 cases with peptic ulcer were randomly divided into treatment group(43 cases)and control group(42 cases),control group were treated with omeprazole combined with clarithromycin and amoxicillin. Treatment group were treated with pantoprazple combined with clarithromycin and amoxicillin. Both groups were treated for 4 weeks,and then compared the clinical efficacy and adverse reactions. Results The total clinical effective rate in treatment group(93.0%)was significantly higher than that in control group(71.4%)(P 0.05),and the adverse reaction rate in treatment group(14.0%) and in control group(26.2%)have no statistical difference(P 0.05). Conclusion Treatment for peptic ulcer with pantoprazple combined with clarithromycin and amoxicillin is an effective and safe treatment,it is worthy for clinical promotion.

About this research paper

What this paper is about

Objective To investigate the efficacy of triple therapy with pantoprazple,clarithromycin and amoxicillin. Methods 85 cases with peptic ulcer were randomly divided into treatment group(43 cases)and control group(42 cases),control group were treated with omeprazole combined with clarithromycin and amoxicillin. Treatment group were treated with pantoprazple combined with clarithromycin and amoxicillin. Both groups were treated for 4 weeks,and then compared the clinical efficacy and adverse reactions. Results The total clinical effective rate in treatment group(93.0%)was significantly higher than that in control group(71.4%)(P 0.05),and the adverse reaction rate in treatment group(14.0%) and in control group(26.2%)have no statistical difference(P 0.05). Conclusion Treatment for peptic ulcer with pantoprazple combined with clarithromycin and amoxicillin is an effective and safe treatment,it is worthy for clinical promotion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy of triple therapy with pantoprazple,clarithromycin and amoxicillin. Methods 85 cases with peptic ulcer were randomly divided into treatment group(43 cases)and control group(42 cases),control group were treated with omeprazole combined with clarithromycin and amoxicillin. Treatment group were treated with pantoprazple combined with clarithromycin and amoxicillin. Both groups were treated for 4 weeks,and then compared the clinical efficacy and adverse reactions. Results The total clinical effective rate in treatment group(93.0%)was significantly higher than that in control group(71.4%)(P 0.05),and the adverse reaction rate in treatment group(14.0%) and in control group(26.2%)have no statistical difference(P 0.05). Conclusion Treatment for peptic ulcer with pantoprazple combined with clarithromycin and amoxicillin is an effective and safe treatment,it is worthy for clinical promotion.

Key concepts: Medicine, Clarithromycin, Amoxicillin, Omeprazole, Internal medicine, Peptic ulcer, Gastroenterology, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of pantoprazple-based triple therapy for peptic ulcer — Research Paper | ScholarLens